Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.

This article discusses methods for quantifying bone turnover based on tracer kinetic studies of the short-lived radiopharmaceuticals 99mTc-MDP and 18F-fluoride. Measurements of skeletal clearance obtained by using these tracers reflect the combined effects of skeletal blood flow and osteoblastic activity. The pharmacokinetics of each tracer is described, together with some of the quantitative tests of skeletal function that have been described in the literature. The physiologic interpretation of quantitative measurements of bone obtained with the use of short half-life radionuclides is discussed, and the advantages and limitations of 99mTc-MDP and 18F-fluoride are compared and contrasted. Currently, 18F-fluoride dynamic positron emission tomography (PET) is the technique of choice for physiologically precise quantitative studies of bone. However, comparable data could probably be obtained by using 99mTc-MDP if methods for single photon emission computed tomography (SPECT) quantitation were improved.

[1]  W. Neuman,et al.  THE CHEMICAL DYNAMICS OF BONE MINERAL , 1959 .

[2]  R. Wootton The single-passage extraction of 18F in rabbit bone. , 1986, Clinical science and molecular medicine.

[3]  J. Barrio,et al.  Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  P. Valk,et al.  Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  T. Budinger,et al.  PET instrumentation: what are the limits? , 1998, Seminars in nuclear medicine.

[6]  J. Fleming,et al.  Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Ekstrand,et al.  Fluoride pharmacokinetics: Its implications in the fluoride treatment of osteoporosis , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. Siegel,et al.  An analytical solution set for a four-compartment mixed mammillary/catenary model. , 1999, Nuclear medicine communications.

[9]  P. Delmas,et al.  Treatment of postmenopausal osteoporosis , 2002, The Lancet.

[10]  I. Mccarthy,et al.  Multiple tracer studies of bone uptake of 99mTc-MDP and 85Sr. , 1989, The American journal of physiology.

[11]  P. Mcnair,et al.  Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism. , 1984, Scandinavian journal of clinical and laboratory investigation.

[12]  P. Marsden,et al.  Differences in Skeletal Kinetics Between Vertebral and Humeral Bone Measured by 18F‐Fluoride Positron Emission Tomography in Postmenopausal Women , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  O. Israel,et al.  Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  F D Thomas,et al.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  P. Delmas,et al.  Biochemical markers of bone turnover , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[17]  M. Blau,et al.  18 F-fluoride for bone imaging. , 1972, Seminars in nuclear medicine.

[18]  I. Fogelman,et al.  Skeletal Nuclear Medicine , 1996 .

[19]  J. Henriksen,et al.  Arterio-venous concentration difference of [51Cr]EDTA after a single injection in man. Significance of renal function and local blood flow. , 1989, Clinical physiology.

[20]  R. Recker,et al.  Bone biopsy and histomorphometry in clinical practice. , 1994, Rheumatic diseases clinics of North America.

[21]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[22]  C. Weaver Use of calcium tracers and biomarkers to determine calcium kinetics and bone turnover. , 1998, Bone.

[23]  Harry K. Genant,et al.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.

[24]  M. Rogers,et al.  Bisphosphonates: from the laboratory to the clinic and back again. , 1999, Bone.

[25]  D. Hamilton,et al.  Body surface area correction in single-sample methods of glomerular filtration rate estimation. , 1999, Nuclear medicine communications.

[26]  S. Papapoulos,et al.  The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates. , 2001, Seminars in nuclear medicine.

[27]  E. M. Renkin Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. , 1959, The American journal of physiology.

[28]  G. Whitford Intake and Metabolism of Fluoride , 1994, Advances in dental research.

[29]  J. Fleming,et al.  Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysis. , 1987, The British journal of radiology.

[30]  J. Loutit Alkaline earth metabolism in adult man , 1973 .

[31]  M. King,et al.  Bone SPECT of the spine: a comparison of attenuation correction techniques. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  J. Digennaro,et al.  Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. , 1998, The Journal of clinical endocrinology and metabolism.

[33]  G. Blake,et al.  Interpretation of bone densitometry studies. , 1997, Seminars in nuclear medicine.

[34]  I. Fogelman,et al.  Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  M. D. Francis,et al.  Bone scanning: radionuclidic reaction mechanisms. , 1976, Seminars in nuclear medicine.

[36]  Charkes Nd,et al.  Studies of Skeletal Tracer Kinetics. III. Tc-99m(Sn)methylenediphosphonate Uptake in the Canine Tibia as a Function of Blood Flow , 1979 .

[37]  M. Feinsod,et al.  Quantitative bone scintigraphy using SPECT. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  E. Siris Paget's Disease of Bone , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  M. Phelps,et al.  Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. , 1993, The Journal of clinical endocrinology and metabolism.

[40]  M. Maisey,et al.  Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function. , 1984, The British journal of radiology.

[41]  N. D. Charkes,et al.  Studies of skeletal tracer kinetics: II. evaluation of a five-compartment model of [18F]fluoride kinetics in rats. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  O. Israel,et al.  In vivo SPECT quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  F. A. Smith,et al.  Renal Clearance of Fluoride.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  G. Hodgson,et al.  The relation of radionuclide uptake by bone to the rate of calcium mineralization. I: Experimental studies using 45Ca, 32P and 99Tcm-MDP. , 1989, The British journal of radiology.

[45]  J. Staffurth,et al.  The measurement of the extracellular fluid volume with radioactive bromine. , 1960, Clinical science.

[46]  P. Tothill,et al.  Invalidity of single‐passage measurements of the extraction of bone‐seeking tracers in rats and rabbits , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[47]  R. Jain,et al.  Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man. , 1978, The American journal of physiology.

[48]  Makler Pt,et al.  Studies of skeletal tracer kinetics. IV. Optimum time delay for Tc-99m(Sn) methylene disphosphonate bone imaging. , 1980 .

[49]  R. Wootton,et al.  Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. , 1988, The Journal of clinical endocrinology and metabolism.

[50]  H. Fleisch,et al.  Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo , 1969, Science.

[51]  P. Bartholdi,et al.  Critical analysis of methods for analysing human calcium kinetics. , 1978, Journal of theoretical biology.

[52]  W. Greig,et al.  The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[53]  C. Philips,et al.  Studies of skeletal tracer kinetics. I. Digital-computer solution of a five-compartment model of [18F] fluoride kinetics in humans. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[54]  J. P. Lavender,et al.  Blood flow and tracer uptake in normal and abnormal canine bone: comparisons with Sr-85 microspheres, Kr-81m, and Tc-99m MDP. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  A. Jones,et al.  Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging. , 1976, Seminars in nuclear medicine.

[56]  F. Jamar,et al.  The importance of endothelium and interstitial fluid in nuclear medicine , 1998, European Journal of Nuclear Medicine.

[57]  J. Ekstrand,et al.  Renal clearance of fluoride in a steady state condition in man: influence of urinary flow and pH changes by diet. , 2009, Acta pharmacologica et toxicologica.

[58]  C. Slemenda,et al.  Rates of Growth and Loss of Bone Mineral in the Spine and Femoral Neck in White Females , 1999, Osteoporosis International.

[59]  A. Schoutens,et al.  Bone Circulation and Vascularization in Normal and Pathological Conditions , 1993, NATO ASI Series.

[60]  D. Hosking,et al.  Studies in man with 18F. , 1972 .

[61]  G Pearce,et al.  The differing tempo of growth in bone size, mass, and density in girls is region-specific. , 1999, The Journal of clinical investigation.

[62]  G. Blake,et al.  Technical principles of dual energy x-ray absorptiometry. , 1997, Seminars in nuclear medicine.

[63]  I. Fogelman,et al.  Bone Scanning in Clinical Practice , 2012, Springer London.

[64]  Montgomery Rd Letter: Serum-albumin in Kwashiorkor. , 1975 .

[65]  A. le Pape,et al.  Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  T. Martin,et al.  The hypercalcemia of malignancy: pathogenesis and management. , 1982, Metabolism: clinical and experimental.

[67]  S. Pors Nielsen,et al.  A single measurement of biochemical markers of bone turnover has limited utility in the individual person. , 1997, Scandinavian journal of clinical and laboratory investigation.

[68]  A. Perkins,et al.  Bisphosphonate Space Measurement in Paget's Disease of Bone Treated with APD , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  M. Grynpas,et al.  Fluoride effects on bone crystals , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[70]  W. Enneking,et al.  99m Tc-polyphosphate: histological localization in human femurs by autoradiography. , 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[71]  J. Lin,et al.  Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.

[72]  I. Edelman,et al.  Anatomy of body water and electrolytes. , 1959, The American journal of medicine.

[73]  S. Ben-Haim,et al.  A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose. , 1989, Seminars in nuclear medicine.

[74]  S. Bang,et al.  Topographical distribution of fluoride in iliac bone of a fluoride‐treated osteoporotic patient , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  M. Francis,et al.  Optimization of the ratio of stannous tin: ethane-1-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[76]  R. Wootton,et al.  The single-passage extraction of 18F in rabbit bone. , 1974, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[77]  D. Tosteson Halide Transport in Red Blood Cells. , 1959 .

[78]  I. Fogelman,et al.  Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[79]  L. Mosekilde,et al.  Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders , 1987, European journal of clinical investigation.

[80]  W. Brenner,et al.  Quantification of diphosphonate uptake based on conventional bone scanning , 1997, European Journal of Nuclear Medicine.

[81]  J Dequeker,et al.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.

[82]  G. Rubini,et al.  A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. , 1992, Nuclear medicine communications.

[83]  D. A. Ross,et al.  Whole-body counting. , 1973, Seminars in nuclear medicine.

[84]  I. Fogelman,et al.  Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. , 1980, Annals of internal medicine.

[85]  I. Fogelman,et al.  99mTc Diphosphonate Uptake Mechanism on Bone , 1987 .

[86]  M. Piert,et al.  Blood Flow Measurements with [15O]H2O and [18F]Fluoride Ion PET in Porcine Vertebrae , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[87]  T. Ota,et al.  Age-related change of technetium-99m-HMDP distribution in the skeleton. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[88]  D. Pearson,et al.  A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[89]  N. D. Charkes Skeletal blood flow: implications for bone-scan interpretation. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[90]  J. Nuyts,et al.  Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[91]  P. Delmas,et al.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. , 1994, The Journal of clinical endocrinology and metabolism.

[92]  G. Hortobagyi,et al.  Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. , 1996, The New England journal of medicine.

[93]  N. D. Charkes,et al.  Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[94]  W. Armstrong,et al.  Distribution, migration and binding of whole blood fluoride evaluated with radiofluoride. , 1960, The American journal of physiology.

[95]  D. Pashley,et al.  Fluoride renal clearance: a pH-dependent event. , 1976, The American journal of physiology.

[96]  J. Ekstrand,et al.  Fluoride bioavailability after intravenous and oral administration: Importance of renal clearance and urine flow , 1978, Clinical pharmacology and therapeutics.

[97]  V. Vigorita,et al.  Localization of technetium‐99m methylene diphosphonate in bone using microautoradiography , 1986, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[98]  A. Peters Bone Turnover in Osteoporosis , 1993 .

[99]  R. Eastell Treatment of postmenopausal osteoporosis. , 1998, The New England journal of medicine.

[100]  R. Wootton,et al.  The clinical measurement of skeletal blood flow. , 1976, Clinical science and molecular medicine.

[101]  E C Frey,et al.  Quantitative single-photon emission computed tomography: basics and clinical considerations. , 1994, Seminars in nuclear medicine.

[102]  I. Fogelman,et al.  The role of positron emission tomography in skeletal disease. , 2001, Seminars in nuclear medicine.

[103]  M. Hooper,et al.  Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.

[104]  G. Hodgson,et al.  The relation of radionuclide uptake by bone to the rate of calcium mineralization. II: Patient studies using 99Tcm-MDP. , 1989, The British journal of radiology.

[105]  R. Lindsay,et al.  SKELETAL UPTAKE OF DIPHOSPHONATE Method for Prediction of Post-menopausal Osteoporosis , 1980, The Lancet.

[106]  W. S. Snyder,et al.  ICRP Publication 20: Alkaline Earth Metabolism in Adult Man , 1973 .

[107]  T. Einhorn,et al.  The Bone Organ System: Form and Function , 2001 .

[108]  D. Taves Electrophoretic Mobility of Serum Fluoride , 1968, Nature.

[109]  P. Mcnair,et al.  GFR-corrected 24-hour whole body retention of diphosphonate: an improved index of bone metabolism. , 1988, Scandinavian journal of clinical and laboratory investigation.

[110]  P. Tothill,et al.  Post-mortem migration of bone-seeking radionuclides in the rat and rabbit and its effect on estimates of bone uptake. , 1978, Clinical science and molecular medicine.

[111]  S. Hughes,et al.  Fluid space in bone. , 1978, Clinical orthopaedics and related research.

[112]  J. Bevan,et al.  Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[113]  C. Marcelli,et al.  Evolution of Lumbar Bone Mineral Content During Adolescence and Adulthood: A Longitudinal Study in 395 Healthy Females 10–24 Years of Age and 206 Premenopausal Women , 1999, Osteoporosis International.